[Advantages of delayed-action intermittent corticotherapy in the treatment of asthma and chronic respiratory insufficiency].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001623:Betamethasone / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D012131:Respiratory Insufficiency / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D001623:Betamethasone
Avantages d'une corticothérapie intermittente retard dans le traitement de l'asthme et de l'insuffisance respiratoire chronique.